Known-group comparisons by frequency of VOCs over prior year
. | <4 VOCs/y (n = 17) . | ≥4 VOCs/y (n = 25) . | P . |
---|---|---|---|
Patient or disease characteristic, n (%) | |||
Age, y | .13 | ||
Mean | 33.1 | 28.2 | |
SD | 11.3 | 6.7 | |
Female sex | 10 (59) | 15 (60) | >.99 |
Non-Hispanic black | 13 (76) | 22 (88) | >.99 |
Hb SS genotype | 9 (53) | 13 (52) | >.99 |
Prescribed hydroxyurea | 8 (47) | 19 (76) | .11 |
Publicly insured | 15 (88) | 22 (88) | >.99 |
Self-reported disability | 6 (35) | 19 (76) | .02 |
High school education level or lower | 8 (47) | 5 (20) | .13 |
Primary caregiver of dependent child | 3 (18) | 6 (24) | .72 |
PROM score at admission, mean (SD) | |||
NRS Pain Score (0-10) | 8.1 (2.5) | 8.6 (1.3) | .45 |
PROMIS Global Physical Health | 38.7 (5.5) | 39.0 (4.7) | .85 |
PROMIS Global Mental Health | 39.4 (6.2) | 44.2 (5.2) | .01 |
ASCQ-Me Emotional Impact | 42.2 (10.1) | 39.4 (8.1) | .36 |
ASCQ-Me Social Functioning | 47.4 (7.7) | 45.9 (7.8) | .53 |
ASCQ-Me Pain Impact | 42.2 (8.6) | 41.9 (4.9) | .89 |
ASCQ-Me Stiffness Impact | 50.2 (7.1) | 46.1 (7.1) | .07 |
ASCQ-Me Sleep Impact | 53.2 (3.6) | 51.2 (4.9) | .14 |
. | <4 VOCs/y (n = 17) . | ≥4 VOCs/y (n = 25) . | P . |
---|---|---|---|
Patient or disease characteristic, n (%) | |||
Age, y | .13 | ||
Mean | 33.1 | 28.2 | |
SD | 11.3 | 6.7 | |
Female sex | 10 (59) | 15 (60) | >.99 |
Non-Hispanic black | 13 (76) | 22 (88) | >.99 |
Hb SS genotype | 9 (53) | 13 (52) | >.99 |
Prescribed hydroxyurea | 8 (47) | 19 (76) | .11 |
Publicly insured | 15 (88) | 22 (88) | >.99 |
Self-reported disability | 6 (35) | 19 (76) | .02 |
High school education level or lower | 8 (47) | 5 (20) | .13 |
Primary caregiver of dependent child | 3 (18) | 6 (24) | .72 |
PROM score at admission, mean (SD) | |||
NRS Pain Score (0-10) | 8.1 (2.5) | 8.6 (1.3) | .45 |
PROMIS Global Physical Health | 38.7 (5.5) | 39.0 (4.7) | .85 |
PROMIS Global Mental Health | 39.4 (6.2) | 44.2 (5.2) | .01 |
ASCQ-Me Emotional Impact | 42.2 (10.1) | 39.4 (8.1) | .36 |
ASCQ-Me Social Functioning | 47.4 (7.7) | 45.9 (7.8) | .53 |
ASCQ-Me Pain Impact | 42.2 (8.6) | 41.9 (4.9) | .89 |
ASCQ-Me Stiffness Impact | 50.2 (7.1) | 46.1 (7.1) | .07 |
ASCQ-Me Sleep Impact | 53.2 (3.6) | 51.2 (4.9) | .14 |